Tag: pharmaceuticals
-
Allos, Mundipharma to Collaborate on Cancer Drugs
Allos Therapeutics in Westminster, Colorado and Mundipharma International Corp. Ltd in Cambridge, U.K. have agreed to co-commercialize the drug Folotyn developed by Allos, a biopharmaceutical company specializing in cancer therapies. Mundipharma is a group of drug development companies in Europe. Folotyn is a folate analogue metabolic inhibitor approved in the U.S. for the treatment of…
-
Challenge Seeks New Pseudoephedrine Production Process
InnoCentive in Waltham, Massachusetts has released a challenge with a $100,000 award for new methods of producing the common medication pseudoephedrine that make it very difficult to extract ingredients for the illegal drug methamphetamine. InnoCentive acts as a marketplace that brings together companies or organizations seeking solutions with groups or individuals interested in providing those…
-
University Patents Chemical Measurement Device and Process
Baylor University in Waco, Texas has received a U.S. patent for a new type of polarimeter, an instrument to measure and interpret transverse waves, such as light waves. The new polarimeter was developed by Baylor chemistry professor Kenneth Busch and lab coordinator Dennis Rabbe. United States Patent 7911608 covers not only the device hardware, but…
-
New Class of Insect Repellant Developed, Patent Filed
Researchers at Vanderbilt University in Nashville, Tennessee have developed a new type of insect repellant that they say is more effective than current products on the market. Their results appear online in the Proceedings of the National Academy of Sciences (paid subscription required). The new type of repellant, from the lab of biology and pharmacology…
-
Math Model Developed to Determine Vaccine Combinations
Engineers and computer scientists at Rochester Institute of Technology in New York and University of Illinois in Urbana have developed a mathematical model to determine the optimum combination of vaccines for children that keeps the injections affordable yet remains financially attractive to manufacturers. The team led by RIT’s Rubén Proaño published their findings last month…
-
New Technology Promises Faster Drug Candidate Testing
Scientists at the Universities of Toronto, Stanford, and Columbia have developed a technology called mass cytometry that measures the action and function of candidate prescription drugs faster and on a larger scale. The team’s findings appear this week in the journal Science (paid subscription required). Mass cytometry enables the measurement of up to 100 biomarkers…
-
One Nation, Under Geeks
Review: Geek Nation by Angela Saini. Hodder & Stoughton (3 Mar 2011). Science writer Angela Saini describes the rise of science and engineering in India in her new book Geek Nation. But if you’re looking for a triumphant Indian victory march you may be disappointed. The book instead offers a sophisticated and nuanced analysis of…
-
California Supporting Embryonic Stem Cell Clinical Trial
The California Institute for Regenerative Medicine (CIRM) awarded a $25 million grant to support the first FDA-approved clinical trial based on human embryonic stem cells. The award to Geron Corporation in Menlo Park, California, will support the company’s early phase trial, already underway, for people with spinal cord injury. CIRM, the state’s stem cell agency,…
-
Unregulated Drug Market Hurting TB Public Health Efforts
The campaign against tuberculosis is generally considered a public health responsibility, but a new study indicates that private, unregulated TB drug sales may be hurting rather than helping those efforts. Results of the study appear in the new issue of the journal PLoS ONE. The research, conducted by the organization TB Alliance and health care…
-
Grant Awarded for New Technology to Develop Polio Vaccine
The Bill and Melinda Gates Foundation has awarded University of Central Florida in Orlando a grant to develop a tablet-based vaccine for polio using a new technology that promises to make vaccines faster, safer, and less expensive. The $761,302 two-year grant will fund research by UCF biotechnology professor Henry Daniell (pictured left). Most vaccines are…